TrialBritish journal of cancer1998

High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.

P Pronzato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.